Lataa...
Increased frequency of angina attacks caused by switching a brand-name vasodilator to a generic vasodilator in patients with vasospastic angina: Two case reports
It is well known that calcium channel blockers (CCBs) are the first line of therapy for vasospastic angina (VSA). Here, we report two cases of VSA with an increase in the frequency of angina attacks after switching from a brand-name to a generic CCB. In both cases, angina recurred upon switching fro...
Tallennettuna:
| Julkaisussa: | World J Cardiol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Baishideng Publishing Group Inc
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867450/ https://ncbi.nlm.nih.gov/pubmed/29588810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4330/wjc.v10.i3.15 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|